$338 Million is the total value of Endurant Capital Management LP's 60 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 85.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Buy | SPDR S&P 500 ETF TRput | $30,772,000 | +28.6% | 91,300 | +17.7% | 9.10% | +593.6% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $23,523,000 | +1008.0% | 390,156 | +980.5% | 6.96% | +5896.6% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $20,527,000 | +13.0% | 1,754,465 | +25.6% | 6.07% | +509.4% |
| EHC | Buy | ENCOMPASS HEALTH CORP | $17,941,000 | +105.2% | 276,105 | +95.5% | 5.31% | +1007.7% |
| ABBV | Buy | ABBVIE INC | $17,423,000 | +183.4% | 198,921 | +217.7% | 5.15% | +1428.8% |
| IART | New | INTEGRA LIFESCIENCES HLDGS C | $13,298,000 | – | 281,608 | +100.0% | 3.93% | – |
| IWM | New | ISHARES TRput | $12,058,000 | – | 80,500 | +100.0% | 3.57% | – |
| CI | Buy | CIGNA CORP NEW | $11,429,000 | +68.6% | 67,461 | +86.8% | 3.38% | +808.6% |
| AHCO | Buy | ADAPTHEALTH CORP | $11,306,000 | +889.2% | 518,377 | +630.1% | 3.34% | +5206.3% |
| JNJ | Sell | JOHNSON & JOHNSON | $11,163,000 | -5.4% | 74,979 | -10.6% | 3.30% | +410.2% |
| SIBN | Sell | SI BONE INC | $10,986,000 | -7.3% | 463,150 | -37.7% | 3.25% | +399.8% |
| ZTS | Sell | ZOETIS INCcl a | $7,766,000 | -22.6% | 46,960 | -35.8% | 2.30% | +317.6% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $7,383,000 | +34.4% | 54,234 | +17.8% | 2.18% | +625.2% |
| CNMD | New | CONMED CORP | $6,388,000 | – | 81,205 | +100.0% | 1.89% | – |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $6,371,000 | +1.3% | 837,137 | +10.8% | 1.88% | +446.1% |
| MCK | Buy | MCKESSON CORP | $6,020,000 | +146.1% | 40,419 | +153.5% | 1.78% | +1228.4% |
| SYNH | Buy | SYNEOS HEALTH INCcl a | $5,962,000 | +87.5% | 112,151 | +105.5% | 1.76% | +913.2% |
| KIDS | New | ORTHOPEDIATRICS CORP | $5,821,000 | – | 126,764 | +100.0% | 1.72% | – |
| XBI | New | SPDR SER TRput | $5,794,000 | – | 52,000 | +100.0% | 1.71% | – |
| Sell | TRILLIUM THERAPEUTICS INC | $5,292,000 | -3.5% | 372,401 | -45.1% | 1.56% | +419.9% | |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $5,051,000 | -46.3% | 135,901 | -25.8% | 1.49% | +189.5% |
| ANTM | Sell | ANTHEM INC | $4,810,000 | -39.1% | 17,909 | -40.4% | 1.42% | +228.4% |
| STRO | Buy | SUTRO BIOPHARMA INC | $4,645,000 | +283.6% | 462,170 | +196.3% | 1.37% | +1981.8% |
| INSM | Buy | INSMED INC | $4,638,000 | +20.1% | 144,313 | +2.9% | 1.37% | +547.2% |
| MTEM | Buy | MOLECULAR TEMPLATES INC | $4,617,000 | +45.7% | 422,787 | +84.0% | 1.36% | +684.5% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,585,000 | -5.2% | 574,502 | +18.9% | 1.36% | +411.7% |
| MBIO | Buy | MUSTANG BIO INC | $4,483,000 | +83.4% | 1,423,050 | +85.2% | 1.33% | +889.6% |
| CNC | Sell | CENTENE CORP DEL | $4,340,000 | -59.8% | 74,408 | -56.2% | 1.28% | +116.7% |
| PDCO | New | PATTERSON COS INC | $3,939,000 | – | 163,415 | +100.0% | 1.16% | – |
| SELB | Sell | SELECTA BIOSCIENCES INC | $3,750,000 | -25.8% | 1,512,069 | -15.0% | 1.11% | +300.4% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $3,682,000 | +31.5% | 1,432,817 | -17.1% | 1.09% | +607.1% |
| VAPO | New | VAPOTHERM INC | $3,645,000 | – | 125,675 | +100.0% | 1.08% | – |
| HAE | Buy | HAEMONETICS CORP | $3,630,000 | +40.0% | 41,607 | +43.8% | 1.07% | +655.6% |
| PETS | New | PETMED EXPRESS INC | $3,348,000 | – | 105,895 | +100.0% | 0.99% | – |
| DGX | New | QUEST DIAGNOSTICS INC | $3,325,000 | – | 29,041 | +100.0% | 0.98% | – |
| CALT | Sell | CALLIDITAS THERAPEUTICS ABsponsered ads | $2,675,000 | -28.0% | 111,467 | -30.4% | 0.79% | +287.7% |
| PRTA | Sell | PROTHENA CORP PLC | $2,625,000 | -37.9% | 262,773 | -34.9% | 0.78% | +234.5% |
| MGNX | New | MACROGENICS INC | $2,453,000 | – | 97,374 | +100.0% | 0.72% | – |
| TBIO | New | TRANSLATE BIO INC | $2,405,000 | – | 176,710 | +100.0% | 0.71% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $2,247,000 | +7.6% | 56,210 | -7.7% | 0.66% | +477.4% |
| ALC | New | ALCON AG | $2,185,000 | – | 38,373 | +100.0% | 0.65% | – |
| New | APTOSE BIOSCIENCES INC | $2,071,000 | – | 345,172 | +100.0% | 0.61% | – | |
| IMUX | New | IMMUNIC INC | $2,060,000 | – | 110,911 | +100.0% | 0.61% | – |
| BIO | Buy | BIO RAD LABS INCcl a | $2,019,000 | +27.6% | 3,916 | +11.7% | 0.60% | +586.2% |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $1,981,000 | +36.9% | 421,398 | +77.7% | 0.59% | +641.8% |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $1,800,000 | – | 117,480 | +100.0% | 0.53% | – |
| DVA | New | DAVITA INC | $1,799,000 | – | 21,002 | +100.0% | 0.53% | – |
| LMNX | New | LUMINEX CORP DEL | $1,788,000 | – | 68,131 | +100.0% | 0.53% | – |
| ALBO | New | ALBIREO PHARMA INC | $1,740,000 | – | 52,131 | +100.0% | 0.52% | – |
| ARCT | New | ARCTURUS THERAPEUTICS HLDGS | $1,479,000 | – | 34,485 | +100.0% | 0.44% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $1,442,000 | – | 23,588 | +100.0% | 0.43% | – |
| CRTX | New | CORTEXYME INC | $1,091,000 | – | 21,827 | +100.0% | 0.32% | – |
| BAX | Sell | BAXTER INTL INC | $1,011,000 | -72.3% | 12,575 | -70.4% | 0.30% | +49.5% |
| AXGN | New | AXOGEN INC | $817,000 | – | 70,209 | +100.0% | 0.24% | – |
| SENSEONICS HLDGS INCnote 5.250% 2/0 | $682,000 | -45.9% | 1,500,000 | 0.0% | 0.20% | +192.8% | ||
| INBX | New | INHIBRX INC | $647,000 | – | 35,935 | +100.0% | 0.19% | – |
| PNTG | New | PENNANT GROUP INC | $528,000 | – | 13,699 | +100.0% | 0.16% | – |
| ADCT | Buy | ADC THERAPEUTICS SA | $396,000 | +92.2% | 12,000 | +172.1% | 0.12% | +963.6% |
| ALRN | New | AILERON THERAPEUTICS INC | $340,000 | – | 263,439 | +100.0% | 0.10% | – |
| CRBP | New | CORBUS PHARMACEUTICALS HLDGS | $162,000 | – | 89,886 | +100.0% | 0.05% | – |
| PCVX | Exit | VAXCYTE INC | $0 | – | -6,827 | -100.0% | -0.01% | – |
| GNCA | Exit | GENOCEA BIOSCIENCES INC | $0 | – | -119,979 | -100.0% | -0.02% | – |
| PODD | Exit | INSULET CORP | $0 | – | -2,465 | -100.0% | -0.03% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -4,148 | -100.0% | -0.03% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -38,494 | -100.0% | -0.03% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -29,575 | -100.0% | -0.04% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -19,677 | -100.0% | -0.06% | – |
| BDX | Exit | BECTON DICKINSON & CO | $0 | – | -6,080 | -100.0% | -0.08% | – |
| XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -35,059 | -100.0% | -0.08% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -30,395 | -100.0% | -0.10% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -24,178 | -100.0% | -0.12% | – |
| IQV | Exit | IQVIA HLDGS INC | $0 | – | -15,773 | -100.0% | -0.12% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -106,338 | -100.0% | -0.20% | – |
| HRC | Exit | HILL ROM HLDGS INC | $0 | – | -35,604 | -100.0% | -0.21% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -81,789 | -100.0% | -0.26% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -99,869 | -100.0% | -0.28% | – |
| HMSY | Exit | HMS HLDGS CORP | $0 | – | -161,914 | -100.0% | -0.29% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -37,915 | -100.0% | -0.34% | – |
| ICUI | Exit | ICU MED INC | $0 | – | -35,556 | -100.0% | -0.36% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -75,828 | -100.0% | -0.38% | – |
| Exit | EVOLENT HEALTH INCnote 2.000%12/0 | $0 | – | -20,156,000 | -100.0% | -0.97% | – | |
| IWN | Exit | ISHARES TRput | $0 | – | -108,600 | -100.0% | -85.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.